Burning Rock Biotech Ltd - ESG Rating & Company Profile powered by AI
The webpage contains a questions and answers table on Burning Rock Biotech Ltd. Browse to the end of this page for potential risks for Burning Rock Biotech Ltd based on industry, location and size. The page displays a free ESG analysis for Burning Rock Biotech Ltd.
Burning Rock Biotech Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.4; made up of an environmental score of 0.0, social score of 0.0 and governance score of 1.3.
0.4
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1924 | Sigma Healthcare Ltd | 0.5 | Low |
1924 | Uni-Bio Science Group Ltd | 0.5 | Low |
1952 | Burning Rock Biotech Ltd | 0.4 | Low |
1952 | CFR Pharmaceuticals SA | 0.4 | Low |
1952 | CellSource Co Ltd | 0.4 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Burning Rock Biotech Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Burning Rock Biotech Ltd disclose current and historical energy intensity?
Does Burning Rock Biotech Ltd report the average age of the workforce?
Does Burning Rock Biotech Ltd reference operational or capital allocation in relation to climate change?
Does Burning Rock Biotech Ltd disclose its ethnicity pay gap?
Does Burning Rock Biotech Ltd disclose cybersecurity risks?
Does Burning Rock Biotech Ltd offer flexible work?
Does Burning Rock Biotech Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Burning Rock Biotech Ltd disclose the number of employees in R&D functions?
Does Burning Rock Biotech Ltd conduct supply chain audits?
Does Burning Rock Biotech Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Burning Rock Biotech Ltd conduct 360 degree staff reviews?
Does Burning Rock Biotech Ltd disclose the individual responsible for D&I?
Does Burning Rock Biotech Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Burning Rock Biotech Ltd disclose current and / or historical scope 2 emissions?
Does Burning Rock Biotech Ltd disclose water use targets?
Does Burning Rock Biotech Ltd have careers partnerships with academic institutions?
Did Burning Rock Biotech Ltd have a product recall in the last two years?
Does Burning Rock Biotech Ltd disclose incidents of discrimination?
Does Burning Rock Biotech Ltd allow for Work Councils/Collective Agreements to be formed?
Has Burning Rock Biotech Ltd issued a profit warning in the past 24 months?
Does Burning Rock Biotech Ltd disclose parental leave metrics?
Does Burning Rock Biotech Ltd disclose climate scenario or pathway analysis?
Does Burning Rock Biotech Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Burning Rock Biotech Ltd disclose the pay ratio of women to men?
Does Burning Rock Biotech Ltd support suppliers with sustainability related research and development?
Does Burning Rock Biotech Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Burning Rock Biotech Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Burning Rock Biotech Ltd involved in embryonic stem cell research?
Does Burning Rock Biotech Ltd disclose GHG and Air Emissions intensity?
Does Burning Rock Biotech Ltd disclose its waste policy?
Does Burning Rock Biotech Ltd report according to TCFD requirements?
Does Burning Rock Biotech Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Burning Rock Biotech Ltd disclose energy use targets?
Does Burning Rock Biotech Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Burning Rock Biotech Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Burning Rock Biotech Ltd
These potential risks are based on the size, segment and geographies of the company.
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass IO, the corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. The company also offers LungCore for lung cancer, ProstrateCore for prostrate cancer, BreastCore for breast cancer, LymphPlasma for lymphomas, and ThyroCare for thyroid cancer. In addition, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. Burning Rock Biotech Limited has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, Sino Biopharm, CStone and BeiGene. The company was founded in 2014 and is headquartered in Guangzhou, China.